itchy skin semaglutide Dermal Hypersensitivity Reaction to Semaglutide: Two Case Reports Doctors explain what's behind Ozempic

Understanding the difference helps you choose an evidence-based approach to weight management

Novo Nordisk has highlighted strong early uptake for its obesity pill in the US in early 2026 , framing oral semaglutide in obesity as part of its growth strategy beyond injectables

Supports healthy digestion and regularity*

Triple therapy combining an SGLT2 inhibitor, a GLP-1 receptor agonist and the thiazolidinedione pioglitazone could serve as an optimal solution for cardiovascular and renal protection in type 2 diabetes, according to a speaker.The impact of triple therapy on CV outcomes remains difficult to discern

If everyday bumps leave their mark, this could be why.

Learn how it works, how it compares to GLP-1 medications, and its current FDA status.